Litcius/Paper detail

Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris

Brandon D. Ayres, Barbara Fant, Zachary C. Landis, Kevin M. Miller, R. Doyle Stulting, Robert J. Cionni, Nicole R. Fram, Stephen Hamilton, David R. Hardten, Douglas D. Koch, Samuel Masket, Francis W. Price, Kenneth J. Rosenthal, M. Bowes Hamill, Michael E. Snyder

2022Ophthalmology18 citationsDOI

Topics & Concepts

MedicineVisual acuityAdverse effectPhotophobiaOphthalmologyGLAREIRIS (biosensor)Clinical trialProspective cohort studyVisual analogue scaleQuality of life (healthcare)SurgeryInternal medicineComputer securityComputer scienceNursingBiometricsLayer (electronics)Organic chemistryChemistryIntraocular Surgery and LensesRetinal and Macular SurgeryOcular Disorders and Treatments
Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris | Litcius